FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology and therapy, and is applicable for assessing the risk of developing chronic kidney disease in males with stage II hypertension. Solves the problem of determining a high-risk group of developing chronic kidney disease in males with hypertension of the second stage for the necessary preventive and therapeutic measures. To assess the risk of developing chronic kidney disease in men with hypertensive disease of the second stage, anamnesis is taken, the level of taste sensitivity to table salt is determined at admission, level of uric acid, Beck’s Depression Inventory score; probability of developing chronic kidney disease is calculated. If the value is more than 0.5, this indicates a high risk of developing complications such as chronic kidney disease; while if the value is less than 0.5, the risk is considered to be low.
EFFECT: invention makes it possible to more accurately identify at early stages groups of high risk of developing CKD among men with hypertensive disease of the second stage, which require an individual plan of dispensary observation, a complex of preventive measures and correction of the main antihypertensive therapy.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING RISK OF DEVELOPING CHRONIC KIDNEY DISEASE IN PATIENTS WITH STAGE II HYPERTENSION | 2024 |
|
RU2823482C1 |
METHOD FOR ASSESSING RISK OF DEVELOPING CHRONIC KIDNEY DISEASE IN WOMEN WITH STAGE II HYPERTENSION | 2024 |
|
RU2823479C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING HYPERTENSION DISEASE AT EARLY STAGE AND NEUROCIRCULATORY DYSTONIA OF HYPERTENSION TYPE | 2001 |
|
RU2184490C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN THE NEXT 12 MONTHS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A COMBINATION WITH EARLY STAGES OF CHRONIC RENAL DISEASE | 2018 |
|
RU2689024C1 |
METHOD FOR DIAGNOSTICS OF PROTEIN-ENERGY INSUFFICIENCY IN ADULT PATIENTS WITH STAGE 3A-5D CHRONIC KIDNEY DISEASE | 2021 |
|
RU2770551C1 |
METHOD FOR PREDICTING ONSET OF DEATH IN COVID-19 PATIENTS AGED 60 YEARS AND OLDER | 2023 |
|
RU2805263C1 |
METHOD FOR ESTIMATING COMPLIANCE LEVEL OF PATIENTS WITH HYPERTENSIVE DISEASE OF I-II STAGE IN ARTERIAL HYPERTENSION OF 1-3 DEGREE | 2014 |
|
RU2556856C1 |
METHOD OF PREDICTING LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH HYPERTENSION | 2011 |
|
RU2456916C1 |
METHOD FOR DIAGNOSING SARCOPENIA IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE RECEIVING TREATMENT WITH LONG-TERM HEMODIALYSIS | 2020 |
|
RU2756154C1 |
METHOD FOR PSYCHOLOGICAL REHABILITATION IN PATIENTS WITH CHRONIC RENAL DISEASE BEING UPON HEMODIALYSIS-BASED THERAPY | 2005 |
|
RU2301688C1 |
Authors
Dates
2024-07-15—Published
2024-02-16—Filed